Pablo Cannata

1.3k total citations · 1 hit paper
14 papers, 879 citations indexed

About

Pablo Cannata is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Pablo Cannata has authored 14 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Nephrology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Pablo Cannata's work include Muscle and Compartmental Disorders (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Dialysis and Renal Disease Management (2 papers). Pablo Cannata is often cited by papers focused on Muscle and Compartmental Disorders (2 papers), Chronic Kidney Disease and Diabetes (2 papers) and Dialysis and Renal Disease Management (2 papers). Pablo Cannata collaborates with scholars based in Spain, Germany and United States. Pablo Cannata's co-authors include José Luis Fernández Martín, Beatriz Martín-Carro, Cristina Alonso‐Montes, Jorge B. Cannata‐Andía, Manuel Naves‐Díaz, Natalia Carrillo‐López, Laura Martínez‐Arias, Sara Panizo, Alberto Ortíz and Jesús Egido and has published in prestigious journals such as Scientific Reports, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Pablo Cannata

14 papers receiving 869 citations

Hit Papers

Fibrosis in Chronic Kidney Disease: Pathogenesis and Cons... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Cannata Spain 11 373 223 182 138 97 14 879
Miguel Fontecha‐Barriuso Spain 14 482 1.3× 180 0.8× 277 1.5× 138 1.0× 85 0.9× 23 932
Cristina García‐Caballero Spain 11 357 1.0× 194 0.9× 230 1.3× 135 1.0× 95 1.0× 20 860
He-He Hu China 11 554 1.5× 273 1.2× 173 1.0× 128 0.9× 156 1.6× 14 1.3k
Guangyi Liu China 14 351 0.9× 129 0.6× 183 1.0× 96 0.7× 104 1.1× 30 871
Lihua Ni China 12 390 1.0× 248 1.1× 125 0.7× 151 1.1× 113 1.2× 39 828
Motoi Kobayashi Japan 15 525 1.4× 359 1.6× 188 1.0× 213 1.5× 123 1.3× 21 1.1k
Christudas Morais Australia 19 483 1.3× 309 1.4× 144 0.8× 205 1.5× 91 0.9× 60 1.0k
Tomohito Doke United States 16 427 1.1× 130 0.6× 328 1.8× 108 0.8× 86 0.9× 24 937
Yuya Horinouchi Japan 19 250 0.7× 231 1.0× 97 0.5× 106 0.8× 61 0.6× 42 890
Laura Márquez‐Expósito Spain 15 400 1.1× 93 0.4× 269 1.5× 77 0.6× 119 1.2× 31 916

Countries citing papers authored by Pablo Cannata

Since Specialization
Citations

This map shows the geographic impact of Pablo Cannata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Cannata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Cannata more than expected).

Fields of papers citing papers by Pablo Cannata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Cannata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Cannata. The network helps show where Pablo Cannata may publish in the future.

Co-authorship network of co-authors of Pablo Cannata

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Cannata. A scholar is included among the top collaborators of Pablo Cannata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Cannata. Pablo Cannata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Roberts, Alexandra A., et al.. (2023). Novel Experimental Mouse Model to Study Malaria-Associated Acute Kidney Injury. Pathogens. 12(4). 545–545. 1 indexed citations
2.
Castelo‐Branco, Regiane Cardoso, et al.. (2022). Crosstalk between TBK1/IKKε and the type I interferon pathway contributes to tubulointerstitial inflammation and kidney tubular injury. Frontiers in Pharmacology. 13. 987979–987979. 9 indexed citations
3.
Panizo, Sara, Laura Martínez‐Arias, Cristina Alonso‐Montes, et al.. (2021). Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. International Journal of Molecular Sciences. 22(1). 408–408. 232 indexed citations breakdown →
4.
Martin‐Lorenzo, Marta, María Gómez‐Serrano, Juan Antonio López, et al.. (2021). Early renal and vascular damage within the normoalbuminuria condition. Journal of Hypertension. 39(11). 2220–2231. 11 indexed citations
5.
Duro‐Castaño, Aroa, Regiane Cardoso Castelo‐Branco, Cristian González‐Guerrero, et al.. (2020). Effective Nephroprotection Against Acute Kidney Injury with a Star-Shaped Polyglutamate-Curcuminoid Conjugate. Scientific Reports. 10(1). 2056–2056. 29 indexed citations
6.
Romacho, Tania, Inés Valencia, Susana Vallejo, et al.. (2020). Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome. Scientific Reports. 10(1). 5386–5386. 85 indexed citations
7.
Rubio‐Navarro, Alfonso, Cristina Vázquez‐Carballo, Melania Guerrero‐Hue, et al.. (2019). Nrf2 Plays a Protective Role Against Intravascular Hemolysis-Mediated Acute Kidney Injury. Frontiers in Pharmacology. 10. 740–740. 41 indexed citations
8.
Fierro‐Fernández, Marta, Verónica Miguel, Laura Márquez‐Expósito, et al.. (2019). MiR‐9‐5p protects from kidney fibrosis by metabolic reprogramming. The FASEB Journal. 34(1). 410–431. 55 indexed citations
9.
Guerrero‐Hue, Melania, Cristina García‐Caballero, Alejandra Palomino‐Antolín, et al.. (2019). Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis‐mediated cell death. The FASEB Journal. 33(8). 8961–8975. 211 indexed citations
10.
Espinosa‐Díez, Cristina, Verónica Miguel, Susana Vallejo, et al.. (2017). Role of glutathione biosynthesis in endothelial dysfunction and fibrosis. Redox Biology. 14. 88–99. 70 indexed citations
11.
Egido, Jesús, et al.. (2017). Glomerulonefritis rápidamente progresiva asociada a endocarditis afebril y anca anti-proteinasa 3. Revista Colombiana de Nefrología. 4(1). 85–85. 1 indexed citations
12.
Rubio‐Navarro, Alfonso, María Dolores Sánchez-Niño, Melania Guerrero‐Hue, et al.. (2017). Podocytes are new cellular targets of haemoglobin‐mediated renal damage. The Journal of Pathology. 244(3). 296–310. 52 indexed citations
13.
Rubio‐Navarro, Alfonso, Mónica Carril, Daniel Padró, et al.. (2016). CD163-Macrophages Are Involved in Rhabdomyolysis-Induced Kidney Injury and May Be Detected by MRI with Targeted Gold-Coated Iron Oxide Nanoparticles. Theranostics. 6(6). 896–914. 47 indexed citations
14.
Fernández‐Figueras, María Teresa, et al.. (2010). Grover Disease: A Reappraisal of Histopathological Diagnostic Criteria in 120 Cases. American Journal of Dermatopathology. 32(6). 541–549. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026